Defining Regional Differences in Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety?

Phillips EJ
Clin Pharmacol Ther. 2019 105 (1): 22-25

PMID: 30120778 · PMCID: PMC6312457 · DOI:10.1002/cpt.1175

MeSH Terms (5)

Asians Humans Stevens-Johnson Syndrome United States United States Food and Drug Administration

Connections (1)

This publication is referenced by other Labnodes entities: